Trulieve schedules November 5 results for Trulieve Cannabis stock

Published on 10/22/2026 at 14:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter results are set for November 5, 2026. Trulieve Cannabis stock costs EUR 9.62 on October 22, 2026 at Lang & Schwarz.

Results date and operating scale

Trulieve set November 5, 2026, for its third-quarter results call.
Second-quarter revenue reached USD 271 million with a 60 percent gross margin.
Trulieve Cannabis stock traded at EUR 9.62 at 2:19 p.m. CEST at Lang & Schwarz on October 22, 2026.

TRUL, US89790E1064, Illustration mit AI erstellt.

Trulieve Cannabis (ISIN US89790E1064) will release its third-quarter 2026 results on November 5, 2026, with an 8:30 a.m. ET conference call, according to Yahoo Finance. The date gives investors the next test of the company's medical-only operating model after its second-quarter reporting period.

November 5 brings the next test

The latest earnings call showed second-quarter revenue of USD 271 million and a 60 percent gross margin. Medical-only revenue was USD 222 million, up 4 percent sequentially, while adjusted EBITDA reached USD 98 million, or a 36 percent margin, according to Benzinga. The comparison matters because the third quarter will include only Trulieve's medical operations after the Harvest deconsolidation.

Management guided to third-quarter revenue comparable with the USD 222 million medical-only figure from the second quarter. The company expects growth in Georgia and Pennsylvania to offset seasonal pressure in Florida, while the medical-only gross margin is expected to remain comparable with 63 percent.

What does debt reduction change?

Trulieve repaid a USD 65 million mortgage on October 7, 2026, reducing reported debt to approximately USD 225 million, PR Newswire reported. The balance-sheet move supports the company's stated expansion plans in Georgia and Texas, but the November figures will show how much operating cash flow remains after growth investment.

Three milestones set the backdrop

Trulieve's chronology runs from its June 10, 2026, New York Stock Exchange uplisting, through the October 7 mortgage repayment, to the October 13 second-quarter call covered by Benzinga. Each step changes the investor lens from access to capital, to leverage, to standalone medical-market execution.

Dates investors can track

The next substantiated date is November 5, 2026, for third-quarter results and the accompanying conference call. The call is scheduled for 8:30 a.m. ET after the financial release, according to Yahoo Finance.

Stock price and reporting date

Trulieve Cannabis was trading at EUR 9.62 at Lang & Schwarz on October 22, 2026 at 2:19 p.m. CEST. The November 5 report will provide the next quantified update on revenue, margins, cash flow and the pace of expansion in Georgia and Texas.

The further course of trading is shown by the continuously updated real-time quote of Trulieve Cannabis stock.